This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Centre for Biological Sciences. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Muthusamy Thangaselvam: Innovator in Stem Cell Research
Introduction
Muthusamy Thangaselvam is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of stem cell research, particularly through his innovative methods for identifying and isolating pluripotent stem cells. His work is crucial for advancing medical research and therapeutic applications.
Latest Patents
Muthusamy holds a patent for a method to identify and isolate pluripotent stem cells using endogenous blue fluorescence. This patent, titled "Method to identify and isolate pluripotent stem cells using endogenous blue fluorescence," provides a novel approach to distinguish pluripotent stem cells from differentiating or differentiated cells. The method utilizes the property of endogenous blue fluorescence emitted from intracellular lipid bodies, serving as an effective marker for the pluripotent state.
Career Highlights
Muthusamy is affiliated with the National Centre for Biological Sciences, where he conducts his research. His work has garnered attention for its potential impact on regenerative medicine and developmental biology. He is recognized for his dedication to advancing scientific knowledge in the field of stem cell research.
Collaborations
Muthusamy collaborates with esteemed colleagues, including Mitradas Madhav Panicker and Radhika Menon. These collaborations enhance the research environment and contribute to the development of innovative solutions in biological sciences.
Conclusion
Muthusamy Thangaselvam is a key figure in stem cell research, with a focus on innovative methods for identifying pluripotent stem cells. His contributions are paving the way for future advancements in medical science and regenerative therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile